Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is leading one of nine new studies awarded total of £2m to use large-scale linked data to address priority research questions that will improve understanding of the pandemic and inform the continued policy response.

Covid data model on world map

Expanding on the incredible work of the UK health research community in supporting policy makers to understand and respond to COVID-19, Health Data Research UK (HDR UK) and The Alan Turing Institute are working in partnership with research teams across the UK to support nine new research projects that tackle ongoing, urgent questions about the virus and support future pandemic preparedness.

The nine projects will be delivered by 16 collaborating universities across Scotland, England, Northern Ireland, and Wales.

The Oxford project is led by Sara Khalid, University Research Lecturer and Senior Research Associate in Biomedical Data Science at NDORMS. 

Funded by UK Research and Innovation (UKRI), the project will ask:

  • What are the biases in ethnicity data and how can they be avoided?
  • What are the differences in risk factors for severe disease between ethnic groups?
  • Can we use data science and machine learning to predict which patients are at increased risk of hospitalisation following COVID-19 infection?

Read the full story on the NDORMS website

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.